Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
作者信息
Virani Salim S, Ballantyne Christie M
出版信息
Curr Opin Lipidol. 2010 Apr;21(2):165-6. doi: 10.1097/MOL.0b013e32833768fd.
PMID:20616632
Abstract
摘要
相似文献
1
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
Curr Opin Lipidol. 2010 Apr;21(2):165-6. doi: 10.1097/MOL.0b013e32833768fd.
2
Current drug treatments for lipid management.
Manag Care. 2002 Sep;11(9 Suppl):4-9.
3
Niacin's role in the statin era.烟酸在他汀时代的作用。
Expert Opin Pharmacother. 2010 Oct;11(14):2291-300. doi: 10.1517/14656566.2010.498818.
4
Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?
Curr Opin Lipidol. 2010 Apr;21(2):161-2. doi: 10.1097/MOL.0b013e32833768ea.
5
Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.使用他汀类药物与烟酸联合疗法针对与低密度脂蛋白和高密度脂蛋白相关的心血管风险。
J Cardiovasc Risk. 2002 Dec;9(6):339-47. doi: 10.1097/01.hjr.0000044518.34172.72.
6
The HALTS trial--halting atherosclerosis or halted too early?HALTS试验——阻止动脉粥样硬化，还是过早停止？
N Engl J Med. 2009 Nov 26;361(22):2178-80. doi: 10.1056/NEJMe0908838. Epub 2009 Nov 15.
7
Combining niacin with statins: does it help heart health?
Johns Hopkins Med Lett Health After 50. 2011 Dec;23(10):1-2.
8
9
[Drug combination therapies for patients with hyperlipidemia and its significance].
Nihon Rinsho. 2001 Mar;59 Suppl 3:566-71.
10
Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?改变血浆低密度脂蛋白和高密度脂蛋白胆固醇：未来有哪些可用的组合？
Am J Cardiol. 2005 Nov 7;96(9A):20K-27K; discussion 34K-35K. doi: 10.1016/j.amjcard.2005.08.004. Epub 2005 Sep 21.
Zotero 插件